Answers to the questions your compliance, clinical, and finance teams actually ask.

A patented point-of-care device for rapid infection screening in skilled nursing and other regulated facilities. It works with rapid lateral flow tests (COVID, flu, RSV, strep), photographs and timestamps each one in under a minute, and produces tamper-evident, auditable records automatically. Your staff read the result; the device preserves the proof.

Today, SNFs rely on rapid infection tests that can be reused, contaminated, or swapped, which leaves facilities exposed to HAI liability and regulatory risk. VynMed flags strip tampering before a result gets logged and produces the forensic record CMS surveyors and attorneys ask for. So when they ask "how do you know?", there's a real answer.

Skilled nursing facilities (SNFs) managing infection screening for COVID, flu, RSV, strep, and other respiratory infections. Any facility that needs point-of-care strip authentication with auditable records.

We're in the design-partner phase and pre-launch. We're lining up our first pilot facilities so we can tune the workflow to real resident care, not a lab benchtop.

A pilot is a short, outcome-focused engagement with a named clinical and administrative sponsor at the facility. You get the device, training, and direct access to our team. We get honest feedback about what actually works on your floor.

It is a per-facility subscription billed monthly through Stripe, with the device rental bundled in: $300 (Small Facility), $650 (Professional), or $1,200 (Enterprise) per month. No per-test or per-device fees. We'll walk you through the tiers on your first call and build an ROI model around your facility count and test volume.

VynMed is built around HIPAA's administrative, physical, and technical safeguards. We sign BAAs with every covered entity we work with. See our Security page for the full breakdown.

Test results and audit logs reside with you (the client) inside an isolated tenant. We do not sell, share, or use resident data for advertising, model training, or secondary research.

VynMed is not FDA-cleared. Today it is an audit and compliance tool: it authenticates the strip and preserves the record, and it makes no diagnostic claim. The lateral flow strips it works with carry their own FDA clearances. We are working with regulatory counsel on the right pathway for any future claim, and we'll share that strategy and timeline during due diligence.

VynMed Inc. is a Delaware C-Corp founded by Walter Bischoff Jr, the inventor named on US Patent 12,308,098 B1. The company is incorporated, has an EIN, an operating bank account, and an issued US utility patent.

Yes. We're raising on a $250K SAFE at a $4M cap, with the use of funds tied to getting the first pilot facilities live. If you're an aligned investor, email [email protected] and we'll get you into the data room.

Email [email protected] or call (702) 900-8503. Real people, small team, fast replies.